K2 Therapeutics
Biotechnology Research • 
San Francisco Bay Area, United States • 11-20 Employees
Company overview
| Headquarters | San Francisco Bay Area, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 11-20 |
Key Contacts at K2 Therapeutics
Thomas Galbo
Ceo
Kevin Carlin
Associate Director Protein Sciences
Chang Liu
Co-Founder
Brandon G. Wong
Co-Founder
Kevin Wright
Senior Director, Research
Nikit Patel
Co-Founder
Gordon Rix
Co-Founder
K2 Therapeutics Email Formats
K2 Therapeutics uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@k2-tx.com), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@k2-tx.com | 55.6% |
{first initial}{last name} | jdoe@k2-tx.com | 44.4% |
About K2 Therapeutics
We discover and evolve antibodies for challenging multi-pass membrane proteins, using uniquely powerful synthetic biology and directed evolution platforms, and develop innovative new therapies.
K2 Therapeutics revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
K2 Therapeutics has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
K2 Therapeutics has never raised funding before.
United Kingdom
Canada
Italy
Czechia
SpainFrequently asked questions
4.8
40,000 users
